Skip to main content
Log in

Evidence for the Formation of Amphotericin B-phospholipid Complexes in Langmuir Monolayers

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To study the interaction of the polyene antifungal amphotericin B with phospholipid Langmuir monolayers and to correlate with stability of phospholipid-stabilized drug emulsions.

Methods. Pressure—area isotherms of mixed monolayers of amphotericin B (0–20 mol%) and different phospholipid types were recorded using conventional Langmuir trough methods. Emulsion stability of amphotericin B-containing lipid emulsions was measured using dynamic light scattering.

Results. Incorporation of amphotericin B into monolayers composed of saturated phospholipids (Lipoid E80-3) had a profound effect on the shape of the isotherm. This effect was directly related to the concentration of amphotericin B in the monolayer. At high drug concentrations, the shape of the isotherms became progressively similar to that of pure DPPC, thus exhibiting regions attributable to phospholipid in different phase states. This effect on isotherm shape was not observed following incorporation of the drug into monolayers composed of the equivalent unsaturated lecithin (Lipoid E80).

Conclusions. These results are interpreted as indicating the formation of an amphotericin B-phospholipid complex, resulting in phase separation within the monolayer. The extent and nature of this phase separation was dependent on both the concentration of drug in the system, and the saturation state of the phospholipid component. The relevance of these observations to the stability of amphotericin B drug emulsions stabilised by saturated and unsaturated phospholipid emulsifiers is discussed. These observations may also be relevant to the toxicity of these, and other novel amphotericin B formulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. H. A. Gallis, R. H. Drew, and W. W. Pickard. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308–329 (1990).

    Google Scholar 

  2. P. D. Hoeprich. Clinical use of amphotericin B and derivatives: lore, mystique, and fact. J. Clin. Infect. Dis. 14 (Suppl. 1), S114–S119 (1992).

    Google Scholar 

  3. M. A. Carlson and R. E. Condon. Nephrotoxicity of amphotericin B. J. Amer. Coll. Surg. 179:361–381 (1994).

    Google Scholar 

  4. J. P. Adler-Moore and R. T. Proffitt. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Lipos. Res. 3:429–450 (1993).

    Google Scholar 

  5. L. S. S. Guo and P. K. Working. Complexes of amphotericin B and cholesteryl sulfate. J. Lipos. Res. 3:473–490 (1993).

    Google Scholar 

  6. A. S. Janoff, W. R. Perkins, S. L. Saletan, and C. E. Swenson. Amphotericin B lipid complex (ABLC): a molecular rationale for the attenuation of amphotericin B related toxicities. J. Lipos. Res. 3:451–471 (1993).

    Google Scholar 

  7. R. C. C. New. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother. 8:371–381 (1981).

    Google Scholar 

  8. N. I. Payne, R. F. Cosgrove, A. P. Green, and L. Liu. Formulation aspects of proliposomes: in-vivo studies of liposomes containing amphotericin B. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 12:276–277 (1985).

    Google Scholar 

  9. N. I. Payne, R. F. Cosgrove, A. P. Green, and L. Liu. In-vivo studies of amphotericin B liposomes derived from proliposomes: effect of formulation on toxicity and tissue distribution of the drug in mice. J. Pharm. Pharmacol. 39:24–28 (1987).

    Google Scholar 

  10. R. L. Juliano, C. W. M. Grant, K. R. Barber, and M. P. Kalp. Mechanism of the selective toxicity of amphotericin B incorporated into liposomes. Mol. Pharmacol. 31:1–11 (1987).

    Google Scholar 

  11. F.C. Szoka, D. Milholland, and M. Barza. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob. Agents Chemother. 31:421–429 (1987).

    Google Scholar 

  12. V. Joly, J. Bolard, L. Saint-Julien, C. Carbon, and P. Yeni. Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipidassociated amphotericin B formulations. Antimicrob. Agents Chemother. 36:262–266 (1992).

    Google Scholar 

  13. C. Washington and S. S. Davis. Nottingham University European Patent Application No. 90913513.9 (1991).

  14. C. Washington, S. J. Taylor, and S. S. Davis. The structure of colloidal formulations of amphotericin B. Int. J. Pharm. 46:25–30 (1988).

    Google Scholar 

  15. D. Forster, C. Washington, and S. S. Davis. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. Pharm. Pharmacol. 40:325–328 (1988).

    Google Scholar 

  16. M. R. Lance, C. Washington, and S. S. Davis. Structure and toxicity of amphotericin B/triglyceride emulsion formulations. J. Antimicrob. Chemother. 36:119–128 (1995).

    Google Scholar 

  17. K. A. Lamb, C. Washington, S. S. Davis, and S. P. Denyer. Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers. J. Pharm. Pharmacol. 43:522–524 (1991).

    Google Scholar 

  18. C. Washington, O. Lutz, and S. S. Davis. Stability of an amphotericin B emulsion formulation. J. Pharm. Pharmacol. 43:93P (1991).

    Google Scholar 

  19. C. Washington and S. S. Davis. The production of parenteral feeding emulsions by Microfluidizer. Int. J. Pharm. 44:169–176 (1988).

    Google Scholar 

  20. C. Washington. The stability of intravenous fat emulsions in total parenteral nutrition mixtures. Int. J. Pharm. 66:1–21 (1990).

    Google Scholar 

  21. R. A. Hann. Molecular structure and monolayer properties. In G. Roberts (Ed.), Langmuir-Blodgett films, Plenum Press, New York, 1990, pp. 19–20.

    Google Scholar 

  22. H. E. Ries, M. Matsumoto, N. Uyeda, and E. Suito. Electron micrographs of cholesterol monolayers. J. Colloid. Interface Sci. 57:396–398 (1976).

    Google Scholar 

  23. O. Albrecht, H. Gruler, and E. Sackmann. Polymorphism of phospholipid monolayers. J. Phys. (Paris) 39:301–313 (1978).

    Google Scholar 

  24. M. E. Losche, E. Sackmann, and H. Mohwald. A fluorescence microscopic study concerning the phase diagram of phospholipids. Ber. Bunsenges. Phys. Chem. 87:848–852 (1983).

    Google Scholar 

  25. R. Peters and K. Beck. Translational diffusion in phospholipid monolayers measured by fluorescence microphotolysis. Proc. Nat. Acad. Sci. USA 80:7183–7187 (1983).

    Google Scholar 

  26. H. M. McConnell, L. K. Tamm, and R. M. Weis. Periodic structures in lipid monolayer phase transitions. Proc. Nat. Acad. Sci. USA 81:3249–3253 (1984).

    Google Scholar 

  27. L. K. Tamm, and H. M. McConnell. Supported phospholipid bilayers. Biophys. J. 47:105–113 (1985).

    Google Scholar 

  28. S. Benita and M. Y. Levy. Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterisation. J. Pharm. Sci. 82:1069–1079 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lance, M.R., Washington, C. & Davis, S.S. Evidence for the Formation of Amphotericin B-phospholipid Complexes in Langmuir Monolayers. Pharm Res 13, 1008–1014 (1996). https://doi.org/10.1023/A:1016046321726

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016046321726

Navigation